New Blood: Former Novartis Exec Transitions to Rubius Therapeutics
New Red-Blood-Cell-Derived Therapies Are Poised to Launch Rubius into the Spotlight.
Improving Human Health: The Promise of Epigenetics
A New Perspective for Genomic Research from Prof. Shankar Balsubramanian
Translating Innovation into Therapies
Antimicrobial Resistance and Drug Commercialization Were Key Topics at the Recent ON Helix Conference in Cambridge, U.K.
Literature Review: Dielectrophoresis to the Fore
Old Methodology Resurrected to Allow Inexpensive Label-Free Separation of Cell Populations
Scientists and Social Media
A study published in PLOS One found that while scientists are yet to widely adopt social media, the ones that do see many possible advantages to using it in the workplace, e.g., a good way to access a large and diverse audience, ease of communicating in snippets, and to communicate with colleagues and share peer-reviewed literature within the scholarly community.
Many scientists use Twitter to communicate specifically with other scientists. Some used it as a forum to share their research directly with the public and media, but most saw it as a tool to share research within their field.